成人唐氏综合征的医疗照护:临床指南
该指南由全球唐氏综合征基金会工作组采用 GRADE 方法制定,针对成人唐氏综合征的10个PICO问题检索文献并形成推荐。共纳入22项研究,最终形成14条推荐和4条良好实践声明,但整体证据基础有限。唯一强推荐为从40岁开始筛查阿尔茨海默型痴呆。
要点
- 唯一强推荐:从40岁开始筛查阿尔茨海默型痴呆。
- 糖尿病筛查推荐更早启动、间隔更短。
- 心血管病风险因素管理、肥胖筛查和骨质疏松评估与普通成人指南一致。
核心结论
- 该指南为成人唐氏综合征的初级保健提供循证推荐,但整体证据基础有限,仅形成1条强推荐。
- 唯一强推荐为从40岁开始筛查阿尔茨海默型痴呆。
研究设计与样本
- 全球唐氏综合征基金会成人唐氏综合征医疗照护指南工作组(n=13)制定10个PICO问题。
- 检索MEDLINE、EMBASE、PubMed、PsychINFO、Cochrane Library和TRIP Database,检索时间从2000年1月1日至2018年2月26日,更新检索至2020年8月6日。
- 采用GRADE方法和Evidence-to-Decision框架,由13名工作组成员及16名额外专家、护士、患者代表和方法学家制定推荐。
主要发现
- 基于分析制定14条推荐和4条良好实践声明。
- 仅1条强推荐:从40岁开始筛查阿尔茨海默型痴呆。
- 4条推荐(管理心血管病风险因素和卒中预防、筛查肥胖、评估骨质疏松继发原因)与无唐氏综合征个体的现有指南一致。
- 2条糖尿病筛查推荐建议更早启动筛查和更短间隔,因成人唐氏综合征中糖尿病患病率高且发病更早。
关键数值与推荐
- 强推荐:从40岁开始筛查阿尔茨海默型痴呆。
- 糖尿病筛查推荐更早启动和更短间隔。
- 心血管病风险因素管理、卒中预防、肥胖筛查和骨质疏松继发原因评估与普通成人指南一致。
临床怎么用
- 在成人唐氏综合征初级保健中,从40岁开始筛查阿尔茨海默型痴呆。
- 对成人唐氏综合征启动更早、间隔更短的糖尿病筛查。
- 管理心血管病风险因素和卒中预防、筛查肥胖、评估骨质疏松继发原因,参照普通成人指南。
局限性
- 整体证据基础有限,限制了推荐的强度。
- 需要额外研究以补充高质量证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Down syndrome is the most common chromosomal condition, and average life expectancy has increased substantially, from 25 years in 1983 to 60 years in 2020. Despite the unique clinical comorbidities among adults with Down syndrome, there are no clinical guidelines for the care of these patients. OBJECTIVE: To develop an evidence-based clinical practice guideline for adults with Down syndrome. EVIDENCE REVIEW: The Global Down Syndrome Foundation Medical Care Guidelines for Adults with Down Syndrome Workgroup (n = 13) developed 10 Population/Intervention/ Comparison/Outcome (PICO) questions for adults with Down syndrome addressing multiple clinical areas including mental health (2 questions), dementia, screening or treatment of diabetes, cardiovascular disease, obesity, osteoporosis, atlantoaxial instability, thyroid disease, and celiac disease. These questions guided the literature search in MEDLINE, EMBASE, PubMed, PsychINFO, Cochrane Library, and the TRIP Database, searched from January 1, 2000, to February 26, 2018, with an updated search through August 6, 2020. Using the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology and the Evidence-to-Decision framework, in January 2019, the 13-member Workgroup and 16 additional clinical and scientific experts, nurses, patient representatives, and a methodologist developed clinical recommendations. A statement of good practice was made when there was a high level of certainty that the recommendation would do more good than harm, but there was little direct evidence. FINDINGS: From 11 295 literature citations associated with 10 PICO questions, 20 relevant studies were identified. An updated search identified 2 additional studies, for a total of 22 included studies (3 systematic reviews, 19 primary studies), which were reviewed and synthesized. Based on this analysis, 14 recommendations and 4 statements of good practice were developed. Overall, the evidence base was limited. Only 1 strong recommendation was formulated: screening for Alzheimer-type dementia starting at age 40 years. Four recommendations (managing risk factors for cardiovascular disease and stroke prevention, screening for obesity, and evaluation for secondary causes of osteoporosis) agreed with existing guidance for individuals without Down syndrome. Two recommendations for diabetes screening recommend earlier initiation of screening and at shorter intervals given the high prevalence and earlier onset in adults with Down syndrome. CONCLUSIONS AND RELEVANCE: These evidence-based clinical guidelines provide recommendations to support primary care of adults with Down syndrome. The lack of high-quality evidence limits the strength of the recommendations and highlights the need for additional research.
引用
- Tsou AY, Bulova P, Capone G, et al. Medical Care of Adults With Down Syndrome: A Clinical Guideline. JAMA. 2020. PMID: 33079159. doi:10.1001/jama.2020.17024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。